Recro Pharma (REPH) Moves to Buy: Rationale Behind the Upgrade

Published on September 16, 2021

Recro Pharma (REPH) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive t...